Most people who struggle with opioids are also managing something else: depression that won’t lift, anxiety that never quiets down, or trauma that’s been buried for years. Co-occurring disorder treatment in Maryland addresses both at once, which turns out to be the only approach that actually works.
What Co-Occurring Disorders Actually Mean
A co-occurring disorder means two conditions are present at the same time: opioid use disorder (dependence on heroin, fentanyl, or prescription painkillers) alongside at least one mental health condition such as depression, anxiety, PTSD, or bipolar disorder. These conditions don’t just happen to show up together. They actively feed each other, and understanding that relationship is the first thing worth getting clear on before you talk to any provider.
According to SAMHSA’s 2022 National Survey on Drug Use and Health, roughly 21.5 million adults in the United States have a co-occurring mental health and substance use disorder. Among people with opioid use disorder specifically, the overlap with conditions like depression and PTSD is especially high. In Maryland, where fentanyl-involved overdose deaths have remained among the highest in the country per capita according to the Maryland Department of Health, the mental health burden layered onto opioid dependence is not a side issue. It is often the central issue.
When you walk into a treatment program, tell your intake counselor what you’ve been feeling emotionally, not just what substances you’ve been using. That context changes the treatment plan.
How Common Is This in Maryland
The Maryland Behavioral Health Administration reports that the majority of people seeking publicly funded substance use treatment in the state have a co-occurring mental health condition. SAMHSA data from 2023 estimates that fewer than 10 percent of adults with co-occurring disorders receive treatment for both conditions simultaneously. The rest either receive no treatment at all or get help for one condition while the other goes unaddressed.
In Maryland, fentanyl now accounts for the overwhelming majority of opioid overdose deaths, according to the Maryland Opioid Operational Command Center. The communities most affected, including parts of Baltimore City and surrounding counties, also carry high rates of trauma exposure, housing instability, and untreated depression. That combination isn’t coincidental.
Why One Condition Makes the Other Worse
The relationship runs in both directions. Opioids reduce emotional pain in the short term, which makes them deeply appealing to someone who is anxious, depressed, or carrying unprocessed trauma. Over time, however, opioid dependence disrupts brain chemistry in ways that worsen depression and anxiety, making it harder to feel anything without using. Untreated mental illness then makes sobriety harder to sustain because the original emotional pain is still there, often amplified.
A 2018 study published in the Journal of Clinical Psychiatry found that patients with opioid use disorder and untreated depression had significantly higher relapse rates than patients receiving integrated treatment for both conditions. The plain-English mechanism: when the mental health piece isn’t treated, opioid use starts to feel like the only thing keeping the symptoms manageable.
Tell your intake counselor about your mental health history on day one. Not because you have to, but because it is the fastest way to get a treatment plan that fits how you actually function.
Why Treating Both Conditions Together Produces Better Results
The single most common reason people cycle through treatment repeatedly is not a lack of willpower. It is treating the addiction while leaving the mental health condition untreated. SAMHSA’s Treatment Improvement Protocol (TIP) 42, which synthesizes decades of clinical research, concludes that integrated dual-diagnosis treatment produces better outcomes than sequential or parallel treatment across nearly every measured category, including retention in care, reduction in substance use, and psychiatric symptom improvement.
The mechanism is straightforward. If depression is driving opioid use, then stabilizing opioid use without addressing the depression just removes the only coping tool in the kit. The underlying distress remains. Treatment that addresses both simultaneously gives the brain a reason to stay sober and the support to manage what comes up when the substances are gone. Understanding what that coordinated care actually looks like in practice makes the difference between entering a program that holds and one that doesn’t.
What Integrated Treatment Looks Like in Practice
Integrated treatment means one care team, one shared treatment plan, and no handoff between a separate addiction clinic and a separate therapist who never talk to each other. In practice, for a patient in Maryland starting treatment for opioid use disorder and depression, integrated care typically looks like this: an intake appointment that includes both a substance use assessment and a psychiatric evaluation; a prescription for buprenorphine or another MAT medication handled by a prescriber who also understands psychiatric medications; and weekly or biweekly therapy sessions with a clinician who knows both the addiction history and the mental health history.
Telepsychiatry has made this model more accessible across Maryland, particularly for patients in areas with limited in-person provider availability. The ability to meet with a prescriber or therapist by video removes one of the most common practical barriers to follow-through.
The Risk of Siloed Care
When addiction treatment and mental health treatment are handled by separate providers who don’t share records or communicate, the patient ends up managing two parallel treatment relationships, which often means falling through the gap between them. A 2019 study in Psychiatric Services found that patients with co-occurring disorders who received fragmented care had 30 percent lower treatment retention rates than those in integrated programs.
Before enrolling in any program, ask one direct question: “Does your psychiatric staff share treatment notes and coordinate care with the addiction treatment team?” The answer tells you quickly whether the program is genuinely integrated or just using the language.
Types of Co-Occurring Disorder Treatment Available in Maryland
Treatment exists on a spectrum of intensity, and the right entry point depends on the severity of both conditions, your living situation, and whether you have a stable support system. Here is how the main settings break down.
Medication-Assisted Treatment (MAT) for Opioid Use Disorder
MAT is the evidence-based standard of care for opioid dependence. The three FDA-approved medications are buprenorphine (often prescribed as Suboxone), methadone, and naltrexone (Vivitrol). SAMHSA’s 2023 guidelines confirm that MAT significantly reduces illicit opioid use, overdose risk, and mortality. For patients with co-occurring mental health conditions, MAT plays a specific role: it stabilizes the physical dimension of opioid dependence so that the brain is no longer in constant withdrawal or craving, which creates the neurological space for mental health treatment to actually land.
When speaking with a provider, ask directly: “Is MAT part of your co-occurring disorder program, and does the prescriber who manages my MAT also coordinate with whoever is managing my psychiatric medications?” If the answer is no, that is a meaningful gap. Proper medication oversight for both conditions under one roof is what makes the integrated model work.
Outpatient and Intensive Outpatient Programs (IOP)
For most people in Maryland, outpatient treatment is the most accessible and realistic starting point. Standard outpatient typically means one to two appointments per week. IOP is more structured, usually running nine to twelve hours per week across three to four days, combining group therapy, individual counseling, and psychiatric support.
IOP is especially relevant for Medicaid patients who need more than standard outpatient support but cannot access residential care. A 2020 study in the Journal of Substance Abuse Treatment found that IOP participants with co-occurring disorders who received integrated psychiatric services had comparable outcomes to residential patients, with the added benefit of maintaining family and work connections during treatment.
Residential and Inpatient Treatment
Residential treatment is warranted when outpatient care cannot maintain safety, typically in cases involving active suicidality, severe psychiatric symptoms that require stabilization, or a home environment that makes recovery impossible. Maryland Medicaid covers inpatient and residential stays for qualifying patients, though bed availability in state-funded facilities varies by region and wait times can be a factor.
The clinical criteria a program uses to recommend residential over outpatient center on three things: safety risk, psychiatric acuity, and the absence of a stable living situation. If a provider recommends residential care, ask them to explain exactly which of those criteria applies to your situation.
Therapy Modalities Used in Dual-Diagnosis Treatment
Three evidence-based approaches show consistent results for co-occurring disorders. Cognitive Behavioral Therapy (CBT) targets the thought patterns that link emotional distress to substance use, helping you recognize and interrupt the cycle before it leads to relapse. Dialectical Behavior Therapy (DBT) builds the distress tolerance and emotional regulation skills that are often underdeveloped in people who have used substances to manage overwhelming feelings. Trauma-informed care acknowledges that a significant portion of people with opioid use disorder have trauma histories, and it shapes how providers approach everything from intake questions to the structure of group sessions.
According to a 2021 review in the Journal of Dual Diagnosis, CBT combined with MAT produced better outcomes for co-occurring opioid use and depression than either approach alone. In your first therapy session, expect to talk about history, not just current use. That’s not a detour; it’s the actual work.
How Maryland’s Medicaid Program Covers Co-Occurring Disorder Treatment
Maryland Medicaid, administered through the HealthChoice program, covers integrated behavioral health and substance use treatment for qualifying enrollees. Coverage typically includes psychiatric evaluation, outpatient therapy, IOP, MAT medications including buprenorphine and naltrexone, and medication management appointments. The Maryland Behavioral Health Administration oversees the behavioral health carve-out within HealthChoice, which is administered through Beacon Health Options.
The gap worth knowing: prior authorization requirements and provider network limitations mean that not every program accepting Medicaid patients will have immediate availability. Coverage is real, but navigating it takes a phone call or two. For a fuller picture of what Maryland’s behavioral health system actually covers and how to access it, that context helps before you start calling programs.
Finding a Medicaid-Accepted Provider in Maryland
SAMHSA’s treatment locator at findtreatment.gov lets you filter by location, insurance type, and whether a program offers co-occurring disorder services. The Maryland Behavioral Health Administration’s provider directory is available through the state health department website. Calling 211 Maryland connects you to a navigator who can identify covered programs in your county and help you understand what your plan includes.
The single most efficient step this week: call 211 Maryland, tell them you are looking for co-occurring disorder treatment and that you have Medicaid, and ask for the two or three closest programs with current availability. That call takes under ten minutes and cuts through most of the search.
What to Do Without Insurance
If you have no coverage, state-funded treatment is available through Maryland’s public behavioral health system. Sliding-scale fees and fully subsidized programs exist at community behavioral health centers across the state. The Maryland Department of Health’s Opioid Operational Command Center coordinates access to crisis services and can connect you to low-barrier entry points. Call 211 Maryland, state that you have no insurance, and ask specifically about opioid treatment programs with open slots. That framing gets you to the right program faster.
What to Look for in a Co-Occurring Disorder Treatment Program
Not every program that advertises dual-diagnosis treatment actually delivers integrated care. Here are the criteria that separate programs doing it well from those applying the label loosely.
Psychiatric Evaluation and Medication Management
Any program treating co-occurring disorders should conduct a formal psychiatric evaluation at intake, not just a substance use assessment. The evaluation should be performed by a licensed psychiatric provider, either a psychiatrist or a psychiatric nurse practitioner, and the findings should directly shape the treatment plan. Programs where psychiatric care in Maryland is handled by the same team coordinating your MAT are structured to catch problems that siloed care misses.
Ask directly: “Does your program have a psychiatrist or psychiatric nurse practitioner on staff who manages both mental health medications and coordinates with whoever is prescribing my MAT?” If the prescribers are separate and don’t share notes, that is fragmented care with a dual-diagnosis label.
Peer Support and Recovery Coaching
A 2020 study published in Psychiatric Services, drawing on data from over 3,000 patients in co-occurring disorder programs, found that access to certified peer recovery specialists was associated with a 22 percent improvement in treatment retention at six months. Peer support works because it provides something clinical staff cannot fully replicate: lived experience of navigating both addiction and mental health challenges in real life.
Ask any program whether certified peer recovery specialists are part of the treatment team, not just available as an add-on. When peer support is woven into the care model rather than offered as optional enrichment, the outcomes are meaningfully better.
Common Mistakes to Avoid When Seeking Co-Occurring Disorder Treatment
Waiting for Mental Health Symptoms to Resolve Before Starting Addiction Treatment
A 2021 report from the National Institute on Drug Abuse found that patients who delayed addiction treatment entry while waiting for psychiatric symptoms to stabilize had worse outcomes than those who entered treatment while symptomatic. The cycle doesn’t break on its own. Mental health symptoms often improve once MAT stabilizes opioid use, but that stabilization only happens if you start. Enter treatment while symptomatic. Providers who specialize in co-occurring disorders expect it and plan for it.
Choosing a Program That Doesn’t Screen for Mental Health Conditions
Not all addiction treatment programs conduct a psychiatric evaluation at intake. Some screen for mood and trauma using validated tools like the PHQ-9 for depression, the GAD-7 for anxiety, and the PCL-5 for PTSD. Others do not. Before enrolling, ask specifically: “What mental health screening tools do you use at intake, and how do the results affect the treatment plan?” A program that cannot answer that question clearly is probably not structured for co-occurring disorder care.
Stopping Medication Too Early
According to a 2019 study in JAMA Psychiatry following 40,000 patients on buprenorphine, discontinuing MAT within the first year was associated with a threefold increase in overdose risk. For patients with co-occurring mental health conditions, stopping MAT prematurely is especially risky because the mental health symptoms that originally drove opioid use are often still being worked through in therapy. Discuss a realistic medication timeline with the prescriber before you start, not after you feel better. Feeling better is not the same as the underlying work being done.
What to Start This Week
One call, that’s all. Dial 211 Maryland, say you’re looking for opioid treatment that also addresses mental health, and ask about programs in your area with current availability. If you already have a provider, bring your full mental health history to the next appointment. If you’ve been thinking about whether virtual care could work for your schedule, understanding how telepsychiatry fits into ongoing treatment is worth five minutes of reading before that call. The simplest version of starting is just picking up the phone.